Levetiracetam Tiefenbacher 1000 mg Filmdragerad tablett

国: スウェーデン

言語: スウェーデン語

ソース: Läkemedelsverket (Medical Products Agency)

有効成分:

levetiracetam

から入手可能:

Alfred E Tiefenbacher (GmbH & Co. KG)

ATCコード:

N03AX14

INN（国際名）:

levetiracetam

投薬量:

1000 mg

医薬品形態:

Filmdragerad tablett

構図:

levetiracetam 1000 mg Aktiv substans

処方タイプ:

Receptbelagt

治療領域:

Levetiracetam

認証ステータス:

Avregistrerad

承認日:

2012-04-12

製品の特徴

SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Levetiracetam Tiefenbacher 250 mg film-coated tablets.
Levetiracetam Tiefenbacher 500 mg film-coated tablets.
Levetiracetam Tiefenbacher 750 mg film-coated tablets.
Levetiracetam Tiefenbacher 1000 mg film-coated tablets.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_Levetiracetam Tiefenbacher 250 mg film-coated tablets_
Each film-coated tablet contains 250 mg levetiracetam.
_Levetiracetam Tiefenbacher 500 mg film-coated tablets_
Each film-coated tablet contains 500 mg levetiracetam.
_Levetiracetam Tiefenbacher 750 mg film-coated tablets_
Each film-coated tablet contains 750 mg levetiracetam.
Excipient with known effect: Each film-coated tablet contains 0.17 mg
of sunset yellow FCF
(E110).
_Levetiracetam Tiefenbacher 1000 mg film-coated tablets_
Each film-coated tablet contains 1000 mg levetiracetam.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet.
_Levetiracetam Tiefenbacher 250 mg film-coated tablets_
Blue coloured, capsule shaped tablets (12,7 x 5,9 mm) with deep notch
on one side.
The
tablets can be divided into equal halves.
_Levetiracetam Tiefenbacher 500 mg film-coated tablets_
Yellow coloured, capsule shaped tablets (16,3 x 7,6 mm)with deep notch
on one side.
The
tablets can be divided into equal halves.
_Levetiracetam Tiefenbacher 750 mg film-coated tablets_
Orange coloured, capsule shaped tablets (18,6 x 8,65 mm) with deep
notch on one side.
The tablets can be divided into equal halves.
_Levetiracetam Tiefenbacher 1000 mg film-coated tablets_
White coloured, capsule shaped tablets (19,1 x 10,2 mm) with deep
notch on one side.
The
tablets can be divided into equal halves.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Levetiracetam Tiefenbacher is indicated as monotherapy in the
treatment of partial onset
seizures with or without secondary generalisation in adults and
adolescents from 16 years of
age with newly diagnosed epilepsy.
Levetiracetam Tiefenbacher is indicated as adjunctive therapy